• From Startup to Global Leader: How CTI is Shaping the Future of Clinical Research in Ohio and Beyond Fierce Biotech Mon, 14 Apr 2025 07:00:00 GMT
• SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In CTI BioPharma C... ACCESS Newswire Thu, 03 Apr 2025 20:23:10 GMT
• cti biopharma, servier's pixuvri fails pivotal non-hodgkin lymphoma study, threatening eu conditional approval FirstWord Pharma Fri, 07 Mar 2025 03:18:47 GMT
• investor network: cti biopharma corp. to host earnings call ACCESS Newswire Sat, 25 Jan 2025 07:32:14 GMT
• Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47M Endpoints News Fri, 01 Nov 2024 07:00:00 GMT
• Sobi, angling to become a major hematology player, touts momentum across several brands Fierce Pharma Tue, 16 Jul 2024 07:00:00 GMT
• cti biopharma announces european medicines agency validation of pacritinib Reuters Sat, 13 Jul 2024 07:00:00 GMT
• cti biopharma announces inducement grants under nasdaq listing rule 5635(c)(4) Quantisnow Wed, 10 Jul 2024 14:08:02 GMT
• cti biopharma presents data from pacritinib program at the 63rd american society of hematology meeting Quantisnow Wed, 10 Jul 2024 10:58:57 GMT
• cti biopharma presents new anemia benefit data from pacritinib program at the 2022 american society of hematology (ash) annual mee... Quantisnow Wed, 10 Jul 2024 10:16:33 GMT
• cti biopharma to present at the jmp securities hematology & oncology summit on monday, december 6 Quantisnow Wed, 10 Jul 2024 09:44:21 GMT
• nccn guidelines® recommend vonjo™ (pacritinib) for the treatment of myeloproliferative neoplasms Quantisnow Wed, 10 Jul 2024 09:42:03 GMT
• cti biopharma presents pivotal data from pacritinib program at the european hematology association (eha) 2022 congress Quantisnow Wed, 10 Jul 2024 09:35:30 GMT
• cti biopharma announces inducement grants under nasdaq listing rule 5635(c)(4) Quantisnow Thu, 04 Jul 2024 12:01:58 GMT
• cti biopharma announces cancellation of its 2023 annual meeting of stockholders Quantisnow Wed, 03 Jul 2024 14:26:51 GMT
• cti biopharma announces inducement grants under nasdaq listing rule 5635(c)(4) Quantisnow Wed, 03 Jul 2024 14:24:22 GMT
• sweden's sobi offers $1.7 billion to buy cti biopharma Yahoo Movies UK Wed, 03 Jul 2024 02:29:36 GMT
• sweden's sobi offers $1.7 billion to buy cti biopharma Yahoo Movies UK Wed, 26 Jun 2024 17:18:39 GMT
• cti biopharma's pacritinib demonstrates positive safety profile in graft-versus-host-disease study AOL Sat, 25 May 2024 22:56:03 GMT
• should you buy cti biopharma (ctic) after golden cross? Yahoo News Australia Tue, 21 May 2024 00:19:00 GMT
• ers international congress 2016 - cti biopharma, uk The Pharma Letter Tue, 14 May 2024 08:40:35 GMT
• analysts expect breakeven for cti biopharma corp (nasdaq:ctic) Yahoo New Zealand News Sun, 12 May 2024 00:50:00 GMT
• analysts expect breakeven for cti biopharma corp (nasdaq:ctic) Yahoo New Zealand News Thu, 09 May 2024 11:05:38 GMT
• ers international congress 2016 - cti biopharma, inrebic The Pharma Letter Wed, 08 May 2024 16:20:17 GMT
• cti biopharma shares soar 83% after swedish orphan biovitrum announces $1.7 billion deal for the biotech MSN Mon, 06 May 2024 20:57:41 GMT
• should you buy cti biopharma (ctic) after golden cross? Yahoo Movies UK Mon, 06 May 2024 14:45:41 GMT
• ers international congress 2016 - sierra oncology, cti biopharma The Pharma Letter Sun, 05 May 2024 18:42:25 GMT
• sweden's sobi issues notes to raise up to a billion dollars The Pharma Letter Fri, 26 Apr 2024 07:00:00 GMT
• cti biopharma announces cancellation of its 2023 annual meeting of stockholders The Globe and Mail Wed, 03 Apr 2024 09:21:55 GMT
• cti biopharma (ctic) reports q4 loss, lags revenue estimates Yahoo Movies UK Tue, 26 Mar 2024 13:07:18 GMT
• cti biopharma (ctic) reports q4 loss, lags revenue estimates Yahoo Movies UK Wed, 20 Mar 2024 13:36:33 GMT
• projected growth of the secondary myelofibrosis market by 2032, predicts delveinsight: key players include geron ... Barchart Tue, 20 Feb 2024 16:47:02 GMT
• here's what cti biopharma corp (nasdaq:ctic) needs to get out of its cash to justify the raise Insider Financial Tue, 20 Feb 2024 10:57:56 GMT
• janus kinase (jak) inhibitor market to witness upsurge in growth during the study period (2020-2034), assesses delveinsight | comp... The Globe and Mail Tue, 13 Feb 2024 08:00:00 GMT
• gsk's omjjara wins ec approval | biotechnology | the pharmaletter The Pharma Letter Mon, 29 Jan 2024 08:00:00 GMT
• Lawyer who used firm's data to trade on pharma deal gets 2-month sentence Reuters Wed, 20 Dec 2023 08:00:00 GMT
• ex-gibson dunn lawyer sentenced to 2 months for insider trades Bloomberg Law Wed, 20 Dec 2023 08:00:00 GMT
• pacritinib by cti biopharma for graft versus host disease (gvhd ... Pharmaceutical Technology Tue, 28 Nov 2023 03:17:34 GMT
• morphosys still plans to file myelofibrosis drug despite mixed phase ... MM+M Online Wed, 22 Nov 2023 08:00:00 GMT
• end-stage renal disease (esrd) drugs market growing rapidly globally | cti biopharma corp, prolong ... Argyle Report Sun, 19 Nov 2023 08:20:34 GMT
• increased understanding of the mechanisms of myelofibrosis helps ... OncLive Thu, 16 Nov 2023 21:52:51 GMT
• brazilian lawyer pleads guilty to insider trading while at gibson ... Reuters Wed, 01 Nov 2023 07:00:00 GMT
• ex-gibson dunn attorney pleads guilty to insider trading charge Bloomberg Law Wed, 01 Nov 2023 07:00:00 GMT
• battling new rivals and bracing for jakafi's patent cliff, incyte shores up growth plan Fierce Pharma Tue, 31 Oct 2023 07:00:00 GMT
• sobi publishes q3 2023 report: strong revenue and solid performance Cision News Mon, 30 Oct 2023 07:00:00 GMT
• elevar therapeutics names brian cunningham vice president of ... BioSpace Mon, 23 Oct 2023 07:00:00 GMT
• dr zhou on ongoing investigations into the treatment of patients ... OncLive Thu, 19 Oct 2023 07:00:00 GMT
• newer-generation jak inhibitors expand myelofibrosis treatment ... OncLive Thu, 19 Oct 2023 07:00:00 GMT
• azacitidine, venetoclax, ruxolitinib shows encouraging responses ... Targeted Oncology Thu, 19 Oct 2023 07:00:00 GMT
• moment of truth for pacritinib and other eu approval hopefuls Pink Sheet Sun, 01 Oct 2023 16:30:02 GMT
• lead investigator provides insight into fda approval of momelotinib ... Pharmacy Times Fri, 29 Sep 2023 07:00:00 GMT
• cti's vonjo shows potential in anemic myelofibrosis patients, promising further market growth Scrip Tue, 19 Sep 2023 04:02:42 GMT
• anemia advantage for gsk's blood cancer therapy could ... Investing.com UK Mon, 18 Sep 2023 07:00:00 GMT
• fda approves gsk myelofibrosis med that has edge over others ... MedCity News Sun, 17 Sep 2023 07:00:00 GMT
• a phase ib trial of avid200, a tgfβ 1/3 trap, in patients with ... Cancer Discovery Fri, 15 Sep 2023 08:21:52 GMT
• who got the work: ulmer attorneys to defend purell maker gojo ... Law.com Fri, 15 Sep 2023 07:00:00 GMT
• tolerability and efficacy of the anticluster of differentiation 47 ... ASCO Journals Wed, 13 Sep 2023 07:00:00 GMT
• gsk's momelotinib submission accepted for review by japanese ... The Pharma Letter Mon, 11 Sep 2023 07:00:00 GMT
• jak inhibitors emerge as a cornerstone therapy for myelofibrosis Targeted Oncology Sat, 09 Sep 2023 07:00:00 GMT
• polycythemia vera market grow rapidly at a cagr of 14% during ... PR Newswire Tue, 05 Sep 2023 07:00:00 GMT
• this week in securities litigation (week of august 28, 2023) Lexology Mon, 28 Aug 2023 07:00:00 GMT
• ex-attorney at top 10 biglaw firm charged with insider trading Above the Law Thu, 24 Aug 2023 07:00:00 GMT
• washington d.c. attorney faces sec insider trading charges Blockchain.News Thu, 24 Aug 2023 07:00:00 GMT
• follicular lymphoma treatment global market report 2023 Yahoo Finance Thu, 24 Aug 2023 07:00:00 GMT
• Former Gibson Dunn visiting lawyer charged with insider trading on pharma deal Reuters Wed, 23 Aug 2023 07:00:00 GMT
• swedish orphan biovitrum trades up after launch of rare cap increase GlobalCapital Wed, 23 Aug 2023 07:00:00 GMT
• former gibson dunn attorney is charged with insider trading Bloomberg Wed, 23 Aug 2023 07:00:00 GMT
• sec charges former attorney at u.s.-based global law firm with ... SEC.gov Wed, 23 Aug 2023 07:00:00 GMT
• sobi resolves on a rights issue of approximately sek 6,024 million (1) Europa Press Tue, 22 Aug 2023 07:00:00 GMT
• allogeneic hematopoietic cell transplantation improves outcome in ... ASCO Journals Tue, 22 Aug 2023 07:00:00 GMT
• bulletin from swedish orphan biovitrum (sobi)'s extraordinary ... Sobi Tue, 15 Aug 2023 07:00:00 GMT
• dri healthcare trust reports second quarter 2023 results Canada NewsWire Mon, 14 Aug 2023 07:00:00 GMT
• listing amendment for life sciences ipos part of bigger aspiration The Edge Singapore Thu, 10 Aug 2023 07:00:00 GMT
• 20 years in, singapore still searches for its biotech success story FierceBiotech Sun, 06 Aug 2023 07:00:00 GMT
• masarova discusses ruxolitinib for polycythemia vera after ... Targeted Oncology Tue, 25 Jul 2023 07:00:00 GMT
• video: new options developing for treating anemia with myelofibrosis Healio Thu, 20 Jul 2023 07:00:00 GMT
• sobi intends to carry out a rights issue of approximately sek 6,000 ... PR Newswire Tue, 18 Jul 2023 07:00:00 GMT
• acquisitions drive growth in pharma and biotech in the first half of 2023 | pharmaceutical | the pharmaletter The Pharma Letter Mon, 03 Jul 2023 07:00:00 GMT
• Sobi and CTI BioPharma Complete $1.7 Billion Acquisition Deal PharmTech Thu, 29 Jun 2023 07:00:00 GMT
• a phase i study of milademetan (ds3032b) in combination with low ... Nature.com Thu, 29 Jun 2023 07:00:00 GMT
• gilteritinib in combination with induction and consolidation ... ASCO Journals Wed, 28 Jun 2023 07:00:00 GMT
• dri healthcare trust announces us$54.8 million debt repayment from cti biopharma corp. Canada NewsWire Mon, 26 Jun 2023 07:00:00 GMT
• sobi has finalized its bid for cti biopharma (update) Marketscreener.com Mon, 26 Jun 2023 07:00:00 GMT
• sobi completes acquisition of cti biopharma corp. usa - english ... PR Newswire Mon, 26 Jun 2023 07:00:00 GMT
• sobi successfully completes tender offer for all outstanding shares of ... Sobi Sat, 24 Jun 2023 07:00:00 GMT
• dr mascarenhas on the initial efficacy of navtemadlin plus ... OncLive Fri, 23 Jun 2023 07:00:00 GMT
• podcast: highlights in hematologic malignancies at asco23 ASCO Daily News Fri, 23 Jun 2023 07:00:00 GMT
• cti biopharma corp (ctic) has risen 0.11% in a week, should you buy? InvestorsObserver Tue, 20 Jun 2023 07:00:00 GMT
• fda delays decision on gsk bone cancer drug acquired in $2b ... BioPharma Dive Fri, 16 Jun 2023 07:00:00 GMT
• dr kremyanskaya on the efficacy of rusfertide in phlebotomy ... OncLive Fri, 16 Jun 2023 07:00:00 GMT
• this medical breakthrough has its origins in singapore The Edge Singapore Thu, 15 Jun 2023 07:00:00 GMT
• novartis to buy seattle biotech firm chinook therapeutics in $3.2b deal GeekWire Mon, 12 Jun 2023 07:00:00 GMT
• dr al-ali on the safety and efficacy of bms-986158 plus ruxolitinib ... OncLive Sat, 10 Jun 2023 07:00:00 GMT
• overall deal value keeps last year's pace as m&a values tumble BioWorld Online Fri, 09 Jun 2023 07:00:00 GMT
• cti biopharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates ... Financial Content Tue, 06 Jun 2023 07:00:00 GMT
• phase ii, open-label study of encorafenib plus binimetinib in ... ASCO Journals Sun, 04 Jun 2023 07:00:00 GMT
• CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders PR Newswire Tue, 30 May 2023 07:00:00 GMT
• sobi commences tender offer for all outstanding shares of common ... Sobi Thu, 25 May 2023 07:00:00 GMT
• sobi agrees to buy cti biopharma for $1.7bn Pharmaceutical Technology Tue, 23 May 2023 07:00:00 GMT
• fastest growing therapy area driven by handful of big hitters The Pharma Letter Mon, 22 May 2023 07:00:00 GMT
• ema accepts sobi's efanesoctocog alfa filing | biotechnology | the pharmaletter The Pharma Letter Fri, 19 May 2023 07:00:00 GMT
• cti biopharma: $1.7bn m&a with 85% premium, expect the deal to go through (ctic) Seeking Alpha Tue, 16 May 2023 07:00:00 GMT
• safety and activity of immune checkpoint inhibitors in people living ... ASCO Journals Tue, 16 May 2023 07:00:00 GMT
• sweden: sobi strengthens haematology franchise with acquisition of cti for us$1.7bn LaingBuisson Mon, 15 May 2023 07:00:00 GMT
• eclipse pv trial begins ropeginterferon alfa-2b dosing in ... OncLive Mon, 15 May 2023 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates arnc, ctic, lthm AccessWire Sun, 14 May 2023 07:00:00 GMT
• $1.7b acquisition to develop rare haematology therapy European Pharmaceutical Review Fri, 12 May 2023 07:00:00 GMT
• sobi: cti acquisition looks like a decent fit but doesn’t appear to create value Morningstar Fri, 12 May 2023 07:00:00 GMT
• servier gains non-hodgkin lymphoma drug from cti biopharma Pharmafile Thu, 11 May 2023 18:49:59 GMT
• Sobi Emerges as Savior for CTI Biopharma Cash Crunch With $1.7B M&A Deal MedCity News Thu, 11 May 2023 07:00:00 GMT
CTI BioPharma Corp(NASDAQ:CTIC) 
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CS...
Website: http://www.ctibiopharma.com
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology